Clinical Trial Update: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of KHK4951 in neovascular age-related macular degeneration; the study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• KHK4951

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Neovascular Age-Related Macular Degeneration (nAMD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING